Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

TSX:AEZS - Post Discussion

COSCIENS Biopharma Inc > Hello from Ceapro
View:
Post by Hopeforthebest on Dec 18, 2023 4:21pm

Hello from Ceapro

Just a word of advise regarding the proposed upcoming merger with Ceapro, gagnon has destroyed the value of Ceapro over the last several years. Ceapro use to be valued in the mid $2 range, with average trade volumes of 2mm plus. In 7 short years gagnon has professed several irons in the pipeline but has shown nothing. Today trading in the $0.22 range usually having between 0 - 20,000 shares traded daily.
Gagnon/Ceapro is running out of money will will nolonger be able to pay his friends and himself the wages they have grown to be accustom too, $500,000 per year plus plus plus. AEZS is a perfect source to continnue the money drain without having to produce results.
VOTE NO TO THE MERGER
Comment by Ciao on Dec 23, 2023 8:47pm
and as a board member on AEZS, Gilles is paid $980K a year...a summary of what AEZS shareholders have suffered; https://stockhouse.com/companies/bullboard/v.czo/ceapro-inc?postid=35799082
Comment by Ciao on Dec 23, 2023 8:52pm
Since being a board member of AEZS since January 2020, the share price has declined 96%. He is paid an obsence amount for being a board member if this info is correct. https://ca.wallmine.com/nasdaq/aezs/officer/2071865/gilles-gagnon Was his appointment back as a board member a mid term plan to merge with CEAPRO? Why else would AEZS pay that absurb compensation of $980K?
Comment by lscfa on Jan 05, 2024 5:51pm
 merger is a bad idea for both companies......aeterna shareholders should vote NO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities